A nine-codon deletion mutation in the cytomegalovirus UL97 phosphotransferase gene confers resistance to ganciclovir

被引:28
作者
Chou, SW
Meichsner, CL
机构
[1] Oregon Hlth Sci Univ, Vet Affairs Med Ctr, Med & Res Serv, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Vet Affairs Med Ctr, Div Infect Dis, Portland, OR 97201 USA
关键词
D O I
10.1128/AAC.44.1.183-185.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A deletion mutation (codons 595 to 603) in the cytomegalovirus (CMV) UL97 gene was recently reported after sequence analysis of leukocyte DNA from a patient receiving ganciclovir. The corresponding viral phenotype was examined by transfer of this mutation to a laboratory CMV strain (strain Towne). The recombinant virus was resistant to ganciclovir (8.4-fold increase in the 50% inhibitory concentration), was sensitive to foscarnet, and replicated normally in cell culture.
引用
收藏
页码:183 / 185
页数:3
相关论文
共 15 条
[1]  
Baldanti F, 1998, ANTIMICROB AGENTS CH, V42, P444
[2]   A 3-NUCLEOTIDE DELETION IN THE UL97 OPEN READING FRAME IS RESPONSIBLE FOR THE GANCICLOVIR RESISTANCE OF A HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATE [J].
BALDANTI, F ;
SILINI, E ;
SARASINI, A ;
TALARICO, CL ;
STANAT, SC ;
BIRON, KK ;
FURIONE, M ;
BONO, F ;
PALU, G ;
GERNA, G .
JOURNAL OF VIROLOGY, 1995, 69 (02) :796-800
[3]  
Chou S, 1999, Transpl Infect Dis, V1, P105, DOI 10.1034/j.1399-3062.1999.010204.x
[4]   FREQUENCY OF UL97 PHOSPHOTRANSFERASE MUTATIONS RELATED TO GANCICLOVIR RESISTANCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES [J].
CHOU, SW ;
GUENTZEL, S ;
MICHELS, KR ;
MINER, RC ;
DREW, WL .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) :239-242
[5]   Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease [J].
Chou, SW ;
Marousek, G ;
Guentzel, S ;
Follansbee, SE ;
Poscher, ME ;
Lalezari, JP ;
Miner, RC ;
Drew, WL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) :786-789
[6]   ANALYSIS OF THE UL97 PHOSPHOTRANSFERASE CODING SEQUENCE IN CLINICAL CYTOMEGALOVIRUS ISOLATES AND IDENTIFICATION OF MUTATIONS CONFERRING GANCICLOVIR RESISTANCE [J].
CHOU, SW ;
ERICE, A ;
JORDAN, MC ;
VERCELLOTTI, GM ;
MICHELS, KR ;
TALARICO, CL ;
STANAT, SC ;
BIRON, KK .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :576-583
[7]   Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments [J].
Cihlar, T ;
Fuller, MD ;
Cherrington, JM .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5927-5936
[8]  
Drew W L, 1993, Clin Diagn Virol, V1, P179
[9]   Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients [J].
Erice, A ;
GilRoda, C ;
Perez, JL ;
Balfour, HH ;
Sannerud, KJ ;
Hanson, MN ;
Boivin, G ;
Chou, SW .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05) :1087-1092
[10]   NOVEL MUTATION IN THE UL97 GENE OF A CLINICAL CYTOMEGALOVIRUS STRAIN CONFERRING RESISTANCE TO GANCICLOVIR [J].
HANSON, MN ;
PREHEIM, LC ;
CHOU, SW ;
TALARICO, CL ;
BIRON, KK ;
ERICE, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) :1204-1205